Robeco Institutional Asset Management B.V. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Robeco Institutional Asset Management B.V. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$362,978
-53.7%
4,052
-56.0%
0.00%
-50.0%
Q2 2023$783,288
+2.9%
9,2000.0%0.00%0.0%
Q1 2023$761,302
+184.7%
9,200
+170.6%
0.00%
+100.0%
Q4 2022$267,410
-98.7%
3,400
-98.3%
0.00%
-98.9%
Q4 2018$20,151,000
-13.9%
203,733
-0.3%
0.09%
-3.2%
Q3 2018$23,402,000
+28.1%
204,261
+0.2%
0.09%
+12.0%
Q2 2018$18,272,000203,7610.08%
Other shareholders
HAEMONETICS CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders